Recent News

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
559 News Items found
Hedvig Hricak (left) and David Scheinberg are members of the new Nanotechnology Center's executive committee, which Dr. Scheinberg chairs.
New Nanotechnology Center Combines Cutting-Edge Science with Memorial Sloan Kettering's Expertise in Patient Care

To take advantage of the growing field of nanotechnology, Memorial Sloan Kettering has established a Nanotechnology Center.
Zvi Fuks
Zvi Fuks Elected to the Institute of Medicine

Zvi Fuks has been elected a member of the Institute of Medicine, one of the highest honors in the fields of health and medicine.
Kenneth Offit
Media Advisory
Genetic Variants May Affect the Risk of Breast Cancer in Women with BRCA2 Mutations

An international study led by researchers at Memorial Sloan Kettering Cancer Center has identified genetic variants in women with <i>BRCA2</i> mutations that may increase or decrease their risk of developing breast cancer.
Samuel Danishefsky
Memorial Sloan Kettering Enters Agreement to Develop New Cancer Drug

As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials.
(From left) The first four authors of the June 24 Cancer Cell study, Barry Taylor, Anuradha Gopalan, Haley Hieronymous, and Nikolaus Schultz.
Sifting Through the Prostate Cancer Genome

A team of Memorial Sloan Kettering clinicians and computational biologists have compiled the largest catalog to date of genetic alterations that occur in prostate cancer.
Study Answers Important Question about Using Carbon Nanotubes in Medicine

A multicenter study led by Memorial Sloan Kettering researchers has answered an important question about the safety of using carbon nanotubes in medicine.
Craig B. Thompson, MD
Craig Thompson Named President of Memorial Sloan Kettering Cancer Center

Craig B. Thompson, MD, has been named the new President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center effective November 2, 2010. His appointment concludes a search that began in January 2010.
Doctors operating
New Facility Eases Patient Experience and Promotes Collaborative Treatment and Research

On June 7 when Memorial Sloan Kettering opened a facility housing the novel Center for Image-Guided Interventions, a suite of endoscopy rooms, and new operating rooms for the Surgical Day Hospital.
Rendering of a primary tumor mass with adjoining blood vessels (shown in red). Cells that have detached from the tumor and entered the bloodstream (shown as spheres) may circle back to the tumor and enhance its growth and aggressiveness.
Circulating Tumor Cells May Spur Cancer by a Previously Unknown Mechanism

A recent Memorial Sloan Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.
Christopher Lima (left) and Derek Tan revealed the mechanism of a key cellular process.
Collaborative Team Advances the Understanding of an Important Activity Inside Cells

A collaborative team of researchers from Memorial Sloan Kettering has determined the mechanism for a biological process that plays a key role in regulating cellular behavior.